Effect of prebiotic and probiotic supplementation on reduced pain in patients with fibromyalgia syn-drome: A double-blind, placebo-controlled randomized clinical trial
Regardless, constipation can contribute to UTIs, and it is well known that both GLP-1 and GLP-1/GIPs, such as tirzepatide, cause decreased GI motility as one of the ways they assist in weight reduction
Featured Clinical Resources Featured Charts and Graphics CHART: Meds That Should Not Be Crushed CHART: Comparison of Weight Loss Products Flu Vaccines for 2025-26 (US) CHART: FAQ: Communicating About Flu Vaccination CHART: COVID-19 Vaccines 2025-26 (US) ALGORITHM: Meningococcal Vaccination FAQ: Med Considerations for Cats & Dogs CHART: Smoking Cessation Drug Therapy
Furthermore, weight loss associated with GLP-1 administration alone often fails to meet the required weight reduction for a particular woman (249)
They are not required to demonstrate efficacy before marketing, unlike licensed medications
Five additional peptides go to a later PCAC meeting before the end of February 2027
